Why the study?
Does unfractionated heparin compared to low-molecular-weight heparin affect platelet aggregation and 12-HETE generation in aspirinated patients undergoing carotid endarterectomy?
Does unfractionated heparin compared to low-molecular-weight heparin affect platelet aggregation and 12-HETE generation in aspirinated patients undergoing carotid endarterectomy?
Heparin administration during carotid endarterectomy induces transient platelet activation via the 12-LOX pathway, with LMWH causing less ADP-stimulated aggregation than UFH.
Answers are grounded in this paper and cite their sources.
LMWH attenuates ADP aggregation rise versus UFH during heparinisation in aspirinated CEA patients; extends evidence on differential heparin-platelet effects.
Previously we demonstrated that heparin administration during carotid endarterectomy (CEA) caused a marked, but transient increase in platelet aggregation to arachidonic acid (AA) and adenosine diphosphate (ADP), despite effective platelet cyclo-oxygenase-1 (COX-1) inhibition with aspirin. Here we investigated the metabolism of AA via platelet 12-lipoxygenase (12-LOX) as a possible mediator of the observed transient aspirin resistance, and compared the effects of unfractionated (UFH) and low-molecular-weight (LMWH) heparin. A total of 43 aspirinated patients undergoing CEA were randomised in the trial to 5,000 IU UFH (n=22) or 2,500 IU LMWH (dalteparin, n=21). Platelet aggregation to AA (4x10⁻³) and ADP (3x10⁻⁶) was determined, and the products of the COX-1 and 12-LOX pathways; thromboxane B₂ (TXB₂) and 12-hydroxyeicosatretraenoic acid (12-HETE) were measured in plasma, and in material released from aggregating platelets.Aggregation to AA increased significantly (~10-fold) following heparinisation (p<0.0001), irrespective of heparin type (p=0.33). Significant, but smaller (~2-fold) increases in aggregation to ADP were also seen, which were significantly lower in the platelets of patients randomised to LMWH (p<0.0001). Plasma levels of TxB2 did not rise following heparinisation (p=0.93), but 12-HETE increased significantly in the patients' plasma, and released from platelets stimulated in vitro withADP, with both heparin types (p<0.0001). The magnitude of aggregation to ADP correlated with 12-HETE generation (p=0.03). Heparin administration during CEA generates AA that is metabolised to 12-HETE via the 12-LOX pathway, possibly explaining the phenomenon of transient heparin-induced platelet activation. LMWH has less effect on aggregation and 12-HETE generation than UFH when the platelets are stimulated with ADP.
No takes yet. Share an insight, caveat, or question.
McMahon et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: